Wafik S. El-Deiry: The Potential for Cancer Hallmark Co-Targeting to Surpass Classical Treatment Concepts
Wafik S. El-Deiry/brown.edu

Wafik S. El-Deiry: The Potential for Cancer Hallmark Co-Targeting to Surpass Classical Treatment Concepts

Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:

“I enjoyed asking Professor Doug Hanahan a question after his wonderful seminar organized by Professor Sendurai Mani at Brown University on April 3, 2026 regarding the potential for cancer hallmark co-targeting to surpass classical treatment concepts in Medical Oncology.”

Watch the video

Other articles featuring Wafik S. El-Deiry on OncoDaily.